Analystreport

Rhythm Pharmaceuticals (NASDAQ:RYTM) was downgraded by analysts at Oppenheimer Holdings, Inc. from an "outperform" rating to a "market perform" rating.

Rhythm Pharmaceuticals, Inc.  (RYTM) 
Last rhythm pharmaceuticals, inc. earnings: 3/8 08:12 am Check Earnings Report
US:NASDAQ Investor Relations: ir.rhythmtx.com